RMD · Categories · Form 4
RMD - SEC Form 4 insider transactions
ResMed Inc. (RMD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for RMD
- Chairman and CEO Michael J. Farrell was granted 48,136 units of ResMed Common Stock and covered exercise/tax liability with 28,180 units of ResMed Common Stock, increasing direct ownership by 4% to 491,729 units (SEC Form 4) to satisfy withholding obligation4 - RESMED INC (0000943819) (Issuer)
- Director Christopher Delorefice was granted 554 units of ResMed Common Stock, increasing direct ownership by 23% to 2,977 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Michael J Rider was granted 5,587 units of ResMed Common Stock and covered exercise/tax liability with 3,084 units of ResMed Common Stock, increasing direct ownership by 24% to 12,919 units (SEC Form 4) (withholding tax)4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Director Ronald R Taylor4 - RESMED INC (0000943819) (Issuer)
- Director Harjit Gill was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 10% to 12,013 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Desney Tan was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 18% to 7,111 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director John Hernandez was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 22% to 6,227 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Karen Drexler was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 10% to 11,711 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Product Officer Justin Leong was granted 10,314 units of ResMed Common Stock (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Carol Burt was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 51% to 3,265 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Peter C Farrell was granted 554 units of ResMed Common Stock, increasing direct ownership by 1% to 52,188 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Jan De Witte was granted 1,109 units of ResMed Common Stock, increasing direct ownership by 29% to 4,881 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Jan De Witte sold $101,673 worth of ResMed Common Stock (429 units at $237.00) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 3,772 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. covered exercise/tax liability with 8,111 units of ResMed Common Stock, decreasing direct ownership by 2% to 471,774 units (SEC Form 4) (tax withholding)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Bloomer Aaron covered exercise/tax liability with 1,095 units of ResMed Common Stock, decreasing direct ownership by 12% to 7,977 units (SEC Form 4) to satisfy withholding tax4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C covered exercise/tax liability with 169 units of ResMed Common Stock, decreasing direct ownership by 0.33% to 51,634 units (SEC Form 4) (withholding obligation)4 - RESMED INC (0000943819) (Issuer)
- Director De Witte Jan covered exercise/tax liability with 60 units of ResMed Common Stock, decreasing direct ownership by 1% to 4,201 units (SEC Form 4) (for tax liability)4 - RESMED INC (0000943819) (Issuer)
- Director Gill Harjit covered exercise/tax liability with 36 units of ResMed Common Stock, decreasing direct ownership by 0.33% to 10,904 units (SEC Form 4) (withholding tax)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J covered exercise/tax liability with 1,944 units of ResMed Common Stock, decreasing direct ownership by 16% to 10,417 units (SEC Form 4) (withholding obligation)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,993 units of ResMed Common Stock at a strike of $146.34 and sold $1,175,089 worth of ResMed Common Stock (4,993 units at $235.35) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J sold $102,000 worth of ResMed Common Stock (400 units at $255.00) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. sold $1,129,637 worth of ResMed Common Stock (4,991 units at $226.33) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Amendment: SEC Form 4 filed by Chairman and CEO Farrell Michael J.4/A - RESMED INC (0000943819) (Issuer)
- Chief Product Officer Leong Justin was granted 6,461 units of ResMed Common Stock, increasing direct ownership by 22% to 35,489 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J was granted 3,230 units of ResMed Common Stock, increasing direct ownership by 34% to 12,718 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. was granted 13,547 units of ResMed Common Stock, increasing direct ownership by 3% to 479,803 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Bloomer Aaron was granted 9,072 units of ResMed Common Stock (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,110,191 worth of ResMed Common Stock (4,991 units at $222.44) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $227,688 worth of ResMed Common Stock (970 units at $234.73) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 51,803 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,026,596 worth of ResMed Common Stock (4,991 units at $205.69) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $1,800,000 worth of ResMed Common Stock (8,000 units at $225.00) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 52,773 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,090,771 worth of ResMed Common Stock (4,991 units at $218.55) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $968,064 worth of ResMed Common Stock (4,991 units at $193.96) as part of a pre-agreed trading plan, increasing direct ownership by 0.01% to 466,256 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J covered exercise/tax liability with 269 units of ResMed Common Stock, decreasing direct ownership by 3% to 9,488 units (SEC Form 4) (tax withholding)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,037,233 worth of ResMed Common Stock (4,991 units at $207.82) as part of a pre-agreed trading plan (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sandercock Brett4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Farrell Michael J.4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Sandercock Brett4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Farrell Peter C4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,252,902 worth of ResMed Common Stock (4,991 units at $251.03) (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $520,440 worth of ResMed Common Stock (2,000 units at $260.22), decreasing direct ownership by 3% to 62,773 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Sandercock Brett sold $254,300 worth of ResMed Common Stock (1,000 units at $254.30), decreasing direct ownership by 1% to 84,495 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,366,436 worth of ResMed Common Stock (4,991 units at $273.78) (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $502,620 worth of ResMed Common Stock (2,000 units at $251.31), decreasing direct ownership by 3% to 64,773 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J sold $13,000 worth of ResMed Common Stock (50 units at $260.00), decreasing direct ownership by 0.51% to 9,691 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Sandercock Brett sold $257,030 worth of ResMed Common Stock (1,000 units at $257.03), decreasing direct ownership by 1% to 85,495 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $497,660 worth of ResMed Common Stock (2,000 units at $248.83), decreasing direct ownership by 3% to 66,773 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,240,065 worth of ResMed Common Stock (4,991 units at $248.46) (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Sandercock Brett sold $241,750 worth of ResMed Common Stock (1,000 units at $241.75), decreasing direct ownership by 1% to 86,495 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J sold $12,088 worth of ResMed Common Stock (50 units at $241.75), decreasing direct ownership by 0.51% to 9,741 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,254,796 worth of ResMed Common Stock (4,991 units at $251.41) (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Farrell Peter C sold $502,940 worth of ResMed Common Stock (2,000 units at $251.47), decreasing direct ownership by 3% to 68,773 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Global General Counsel Rider Michael J sold $12,208 worth of ResMed Common Stock (50 units at $244.16), decreasing direct ownership by 0.51% to 9,791 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Chief Financial Officer Sandercock Brett sold $244,160 worth of ResMed Common Stock (1,000 units at $244.16), decreasing direct ownership by 1% to 87,495 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Chairman and CEO Farrell Michael J.4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Director Farrell Peter C4 - RESMED INC (0000943819) (Issuer)
- Director De Witte Jan sold $524,025 worth of ReMed Common Stock (2,055 units at $255.00), decreasing direct ownership by 33% to 4,261 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- SEC Form 4 filed by Director Mowad-Nassar Nicole4 - RESMED INC (0000943819) (Issuer)
- Chief Product Officer Leong Justin was granted 1,848 units of ReMed Common Stock, increasing direct ownership by 7% to 29,028 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
- Director Hernandez John was granted 1,073 units of ResMed Common Stock, increasing direct ownership by 27% to 5,118 units (SEC Form 4)4 - RESMED INC (0000943819) (Issuer)
Other RMD categories
Is something on this page wrong? Request a change